Showing 2481-2490 of 23150 results for "".
A Hopeful Beginning for Malaria Vaccines
https://reachmd.com/programs/focus-on-global-medicine/a-hopeful-beginning-for-malaria-vaccines/4043/Each year, over one million people die of malaria and its complications. Can malaria ever be eliminated, and is a malaria vaccine the answer? Speaking with host Dr. Mary Leuchars on this important subject is Dr. William Collins, senior biomedical research scientist at the Centers for Disease ControlApplying Real-World Data from SABCS 2025 to HR+ HER2- Breast Cancer Care
https://reachmd.com/programs/project-oncology/real-world-data-sabcs2025-breast-cancer-care/36165/Real-world evidence presented at the 2025 San Antonio Breast Cancer Symposium (SABCS) is helping to identify treatment gaps and guide clinical decision-making for hormone receptor-positive, HER2-negative (HR+ HER2-) advanced breast cancer. From advances in ESR1 testing to explorations of frontline CPediatric Flu Vaccination: Strategies for Addressing Parental Concerns
https://reachmd.com/programs/vaccination/pediatric-flu-vaccination-strategies-for-addressing-parental-concerns/36268/Pediatric influenza vaccination rates are consistently lower than other childhood immunizations, a problem that’s often driven by parental hesitancy. Whether it's a lack of understanding of the possible severity of the flu or deeply held beliefs about the vaccine's safety, knowing how to address parThe Aryl Hydrocarbon Receptor and Lupus: Diagnostic and Therapeutic Advancements
https://reachmd.com/programs/living-rheum/the-aryl-hydrocarbon-receptor-and-lupus-diagnostic-and-therapeutic-advancements/28634/Explore the connection between the aryl hydrocarbon receptor and systemic lupus erythematosus and uncover its potential to improve treatment options.Optimizing Quality & Safety Systems to Reduce the Risk of Patient Harm
https://reachmd.com/programs/project-oncology/optimizing-quality-safety-systems-to-reduce-the-risk-of-patient-harm/15269/Here’s how current quality and safety systems are helping to reduce the risk of harm among oncology patients.Global Aesthetics: Laser Advances
https://reachmd.com/topics/energy-based-devices/global-aesthetics-laser-advances/35224/Focal point technology lasers have the potential to fill a void in the aesthetic market for darker skin types.The Art and Science and Sustainable Healthcare Architecture
https://reachmd.com/programs/conversations-on-health-care/the-art-and-science-and-sustainable-healthcare-architecture/7077/This week, Mark and Margaret speak with Robin Guenther, Principal of Perkins+Will and Senior Advisor to Health Care Without Harm. Healthcare Design magazine named her the "#1 Most Influential Designer in Healthcare" in 2010. She co-coordinated the Green Guide for Health Care and co-released the secoDr. Robert C Young on Clinical Research Advances at ASCO
https://reachmd.com/programs/oncology-power-hour/dr-robert-c-young-on-clinical-research-advances-at-asco/6774/The American Society of Clinical Oncology (ASCO) Conference brings over 30,000 people each year and has a membership of over 33,000, a third of which are international. Discussing important clinical research updates unveiled at this event by scientists from across the world is Dr. Robert C. Young, PGrowing Prevalence of Asthma in Seniors
https://reachmd.com/programs/focus-on-geriatric-medicine-and-aging/growing-prevalence-of-asthma-in-seniors/4435/When older patients present with shortness of breath or fatigue, physicians may test for heart failure. Asthma is another diagnosis to consider, since a growing number of seniors have the condition. Dr. Richard deShazo, the Billy S. Guyton Distinguished Professor and professor of medicine and pediatThe Science and Art of Micro-Bubble Contrast Agents
https://reachmd.com/programs/advances-in-medical-imaging/the-science-and-art-of-micro-bubble-contrast-agents/4233/Many clinicians are well familiarized with standard contrast agents such as barium and iodinated compounds to enhance angiographic imaging. Ultrasound, capable of visualizing bloodflow with the use of doppler alone, is yet insufficiently sensitive to capture perfusion of organs and/or tumors at the